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S_qy Long-term srvivors of head and neck cancer may suffer from psychological distress and reduced
quality of life beause of late side-effects of the treatmenLt. In a follow-up study of patients randomised to two
different radiation f onatin egimens, 204 patients filled in a mailed questionnaire 7-11 years after
treatment The quesionnaire conied of the Genral Health Quetonnaire, 20-item ersion (GHQ-20), and
the EORTC Core Quality of Life Questionnaire (EORTC QLQ-C30). There were no differences i
psycholoicl distress betwen ts ving conventional radiotherapy and those receiving a slightly
hypofractionated regimen. A high prevakne of psychological diste was found is both treatment groups
(30'!. of 'ca' ing to the GHQ-20), especially in patiets with impaired cognitive or social function, or
with pain. Oinians need to be aware ofthis morbxity, and their abilty to detect patients with psycholical
problms needs to be impro The GHQ-20 can faclitate the communicaon process in a clnical setting.
With an increased awaren of these and by valid instruments for identifiCation of patients at
risk, the ciniians may mtervne and help the patients to reduce their psychological distress.
Keywwc head and neck neoplasms psycholgcal distress; radiotherapy-, questonnairs long-term survivors
The psychological distress in head and neck cancer patients
may to some extent be related to the high pevakn in this
patient population of chronic excessve use of alcohol and
tobacco and also to the assocated factors of low socio-
economic status, a low level of education and a poor socil
network with little support (Breibart and Holland, 1988). It
may also be related to physical factors caused by the cancer
itself, to side-effects of the treatment or both. The patients
often undergo a long and physically dandg multimodal
treatment surgery and radiotherapy, sometimes combined
with chemotherapy. Many patients suffer from chronic,
visible effects of treatment, e.g. petmanent difigurement, and
permanent loss of functions such as the ability to eat nor-
mally, loss of taste and dry mouth.
Inceased klvels of psychological distr after treatment
have been found in some studies (David and Barritt, 1977,
1982; Olson and Shedd, 1978; Drettner and Ablbom, 1983;
Morton et al., 1984; Dropkin, 1989). There are few studies
describing the psychological distress in cured head and neck
cancer patients (Gotay and Moore, 1992), since most of them
focus on the period of treatment and/or the first few subse-
quent year(s). Furthermore, few standardised ass ents
have been made quanfifying the level of psychological dis-
tress or the frequency/prevakln of patients classified as a
'case' according to valdated questionnaires or psychiatic
criteria such as DSM HI (American Psychiatric Association,
1980). Those that have been arried out all indicate that
psychological diste is a sizeable problem among such
patients. For example, in one such study, 19 out of 48
patients (40%) with buccopharyngeal cancer were shown to
be depressed, and 24 patients (50%) had evidence of dys-
phonic mood more than 6 months after treatment (Morton et
al., 1984). An increased risk of suicide has also been found
among head and neck cancer patients compared with other
cancer patients (Bolund, 1985).
Much research has been done on the psychological
sequelae following the diagnosis and treatment of cacer in
other groups of cancer patients (Craig et al., 1974; Derogatis
et al., 1983; Fobair et al., 1986; Van Dongen-Mehnan and
Sanders-Woudstra, 1986; Huges, 1987; Kaasa et al., 1991;
Kornblith et al., 1992; Olweny et al., 1993). These studies
indicate that being physically cured of cancer does not neces-
sarily mean that patients are psychologialy fit. A knowkge
of the levl of psychological distress in long-term, survivors
and the risk factors associated with it could help to identify
patients at risk, and provide an opportunity to prevent,
reduce or treat such problems. It is hoped that this will help
patients to cope more effectively and to improve their quality
of life.
In a clnical tril at the Norwegian Radium Hospital
(NRH), 845 patients were randomised between 1979 and
1984 to receive radiotherapy either as a conventional
I 2 Gy per fraction 5 days a week (CR), or as a
hypofractionated reipmen, 2.35 Gy per fraction 4 days a
week (HR). The two radiotherapy regimens were assumed to
be radiobiologially equivalent, and thus to give a siilar
survivaL Later research in breast cancer patients showed that
hypofractionated rgmens may give rise to more late side-
effects as well as shorter survival (Turesson and Notter,
1984), but the differences in the number and size of fractions
between the conventional and the hypofractionated regimen
were significntly larger than those in the present study.
A follow-up study of the surviving patients was performed
7-11 years after treatment by means of a patient's self-report
questionnaire assessing health-related quality of life with a
special focus on psychological ditress. The patients' health-
related quality of life was described in a previous paper
(Bjordal et al., 1994). Patients in the HR group reported a
similar or better quality of life than patients in the CR
group. Patients in both groups reported a high level of
symptoms. It could be concluded that a reduction in frac-
tions from five or four per week and a small increase in
fraction size from 2 Gy to 2.35 Gy per day gave no increase
in late side-effects or reduction in health-related quality of
life.
The present paper evaluates the level and indicators of
psychological distress in these surviving head and neck
cancer patients 7-11 years after treatment. Based on
previous findings (Bjordal et al., 1994), we did not assume a
higher level of psychological distress in patients receiving
hypofractionated radiotherapy than in patients receiving con-
ventional radiotherapy. However, we expected to find a
positive assocation between psychological distress and
treatment-related side-effects in the total patient population,
independent of the randomisation.
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Materas and wthos
Patient selection
In January 1991, 252 (30%) of the 845 patients included in
the randomised study were still alive. Four patients died
during the following weeks in the beginning of 1991 (not of
head and neck cancer), and one had moved to an unknown
address. The remaining 247 patients (all disease free) were
included in the present study, and received a mailed question-
naire. One follow-up request was received and 213 patients
(86%) retuned the questionnaire. Nime were excluded owing
to missing data. Thus, data from the remaining 204 (83%)
patients were used in the analyses.
There were no statstically significant differences between
patients receiving conventional radiotherapy (CR, n = 103)
and those receiving hypofractionated radiotherapy (HR,
n = 101) with regard to age, gender, cohabitation, education
or tumour site. The mean age was 67 years (range 32-92);
76% were men; 70% were living with a spouse; and 43%
only had compulsory school education. Half of the patients
had been treated for laryngeal cancer, 22% for cancer in the
oral cavity and the rest for various cancers in the head and
neck region. The surviming patients in the CR group had
more advanced disease at the start of treatment (39% stage
m/m and the recurrence rate was higher (16%) than in the
HR group (25% stage m/Iv and 7% recurrence rate) (Bjor-
dal et al., 1994).
Thepatient self-report questionnaire
The General Health Questionnar, 20-item version, (GHQ-
20) (Goldberg and Williams, 1988) was mailed to the patients
togther with a multidimensional health-related quality of life
questionnaire, the EORTC QLQ-C30 (European Organiz-
tion for Research and Treatment of Cancer Core QOL Ques-
tionnaire, 30-item version) (Aaronson et al., 1993), a 19-item
diagnosis-sific module for head and neck cancer patients
(Bjordal and Kaasa, 1992), two general well-being questions
from the Nord-Tr0ndelag Health Survey (Holmen et al.,
1990), and items indcating sociodemographic variabes.
The General Health Questionnaire (GHQ), a well-
established patient self-report instrument, is designed as a
screening instrument for psychiatric disorders in community
and non-psychiatric clinical settings (Goldberg and Wlliams,
1988). The questionnaire focuses on interruptions in normal
psychological funcion rather than on lifelong traits. Unhlke
the diagnostic system of the DSM-III (the Diagnostic and
Statistical Manual of Mental Disorders) (Anmrican Psychiat-
ric Association, 1980), the GHQ is sensitive to transient
disorders, which may remit without treatment. The original
60-item questionnaire (GHQ-60) includes items covering four
main areas: (1) depression/unhappiness, (2) anxiety/psycho-
logical disturbance, (3) objectively observable behaviour in-
cluding soc impairment/social inadequacy and (4) hypo-
chondriasis. In terms of the DSM-HI system, the question-
naire does not attempt to detect personality disorders,
patterns of sexual adjustment or lifelong phenomena such as
stuttering. Nor does it attempt to detect mental subnor-
mality, senile dementia or mania, since most of these indivi-
duals would be unable to complete a questionnaire. GHQ-20,
a short form of the questionnaire, is speially designed for
somatically ill patients. Items asg somatic symptoms of
anxiety and depion are exclhued. In contrast to many
other psychological distres instuments, the GHQ-20 has a
blanced 'overaII agreement set', includng both positively
phrased items, agreement with which indicates psychological
health, and negatively phrased item agreement with which
indicates psychologial distre.
The items are scored on four-point response scales (Table
1), ranging from 'better than usual' (score = 0) to 'much kss
than usual' (score= 3) (positively phrased items) or 'less than
usual' (score =0) to 'much more than usual' (score = 3)
(negatively phrased items). The 20 single items are then
summed (named likert score), giving a possible scoing
range from 0 to 60. An altenative scoring procedure is the
GHQ score, which can be used for identfying 'cases'. The
four response categories are treated as a binary response
scale (scores 0 or 1), giving a possible scoring range of 20.
With a cut-off point for 'case' identification between 3 and 4
in the GHQ-20, the sesitivity and specificity were 78% and
85% respectively compared with DSM-Il criteria (Goldberg
and Wilams, 1988). This was used for estimation of the
prevalen of 'true cases' in the present population (Table I).
The EORTC QLQ-C30 comprises sui multi-term function
scales measuring physical, role, sociaL emotional and cog-
nitive function, and overall quality of life (Aaronson et al.,
1993). Three multi-item symptom scales measure pain,
fatigue and emesis; six single items measure bowel function,
breathing, appetite, sleping disturbances and economic con-
sequences of the disease. The emotional function scale and
the singe items were not included in the model for the
multivariate analyses of the relationship between
psychological distress and independent variables.
The 19-item head and neck cancer module, which has been
developed at the NRH (Bjordal and Kaasa 1992), was
designed to be used together with the EORTC QLQ-C30.
The module is now being further developed along the
guidelines laid down by the EORTC Study Group on Quality
of Life (Sprangers et al., 1993). The module included items
assesing symptoms and side-effects epeally reklvant to
head and neck cancer patients. In order to reduce the
number of variables in the analyse, we tried to establsh
subscles within the module based on face validity, inter-item
correlations, factor analyses and internal consistency in the
present data set. This approach resulted in a three-item 'swal-
Tab I Exampes of scoring with the General Health Questionnaire (GHQ-20)
Have you recently been able to concentrate
on whaver you're doing?
Better Sant Less Much ls Posible
than usual as usual tha usual than usual range
Likert score 0 1 2 3 0-6Or
GHQ scoreb 0 0 1 1 0-200
'High score, high kvel of psychological distre. bCut-off point for case between 3
and 4.
Tale II Calculation of estimated prevalence of 'true DSM-I caes'
[% cases (100-specificity)] [31 -(I00- 85)j
Estimated prvakncea = sensitivity _100 - spcificity = 78 - (100-85) = 25.4
100 100 100 100
'Based on sensitivity = 78% and specificity = 85% (Goldberg and Willams, 1988).Ps0binh0ci Gibe. K Bordl and S Kaasa
lowing problem' scale which included items assssing prob-
lems with swallowing in general, trouble with swallowing
bread and a tedency to swallow the wrong way. The factor
loadings were 0.88, 0.75 and 0.43 for the three items respec-
tively, and Cronbach's alpha for the scale was 0.83. No other
scales were established.
All scales and single items in the EORTC QLQ-C30 and in
the head and neck cancer module are scored on categorical
scale most of them with four categories (Table IH). In
accordance with the scoring instrutions given by the
EORTC Quality of Life Study Group, the scale scores are
linearly transformed to 0-100 scores. A high score means a
high level of functioning or a higher klvel of symptoms. In
addition to the 'swallowing problem' scale, four of the items
in the module with the highest mean scores in the entire
group were included in the multivariate analyses: coughing,
trouble with taste, dryness in the mouth and mucus produc-
tion (mean scores 25, 21, 35 and 32 reively).
Statistical analyses
The statistical software SPSS PC+ version 4.0 was used in
the statistical analyses. Differences in psychologial distress
between groups were tested with analysis of vanance
(ANOVA) (Ukert score) or chi-square tests (GHQ score).
The multivariate associations between psychological distrs
and the independent variables were tested both by stepwise
multiple regression analyses (ilkert score) and by stepwise
logistic regression (GHQ score). Transformation (square root
and log) or the Likert score in the multiple regression
analyses did not change the results.
Twenty-three indepenent variables were tested; the 12
QOL variables in Table IV and 11 dinia/m pi
variables: age, gender, level ofeducation, lving alone or not,
randomisation (2 Gy x 5 vs 2.35 Gy x 4), disea site, disease
stage, relapse (no/yes), secondary canr (no/yes), the kind of
surgery performed (none, minor, major), and whether the
radiotherapy was given pre- or post-operatively. The QOL
variables were treated as both continually and dichotomised
response scales/items in the regression analyses with similar
results. Results are reported for the dichotomised response
scales/items (high/low - cut-off point at 50).
Because of the multiple testing, the staisical signifi
level of 0.01 was used in the analyses.
RdAts
The level of psychological distress measured by the GHQ-20
was similar in both treatment groups (the CR group and the
HR group). The mean Likert scores (s.d.) in the CR and HR
groups were 20.8 (10.0) and 19.7 (8.3) respely. The pro-
portion of 'cases' (GHQ score>3) was 31% in the CR
group and 32% in the HR group, giving an estimated cal-
culated prevalence of'true DSM-IH cases' of25% (Table II).
Thus, in the subsequent univanate and multivariate analyses,
the patients in the two groups were analysed together.
There were no statistically significant bivariate associations
between psychological distress (the dependent variable) and
independent sociodemographic or clinical variables such as
age, gender, whether or not patients were living with spouse,
level of education, diagnosis, stage of disease or treatment
modality. Nor did recurrence after the randomised treatment
(n =23) or secondary primary cances (n = 19) influence the
level of psychological distress.
Patients reporting low physical, role, social or cognitive
function or a high level of pain, fatigue or emesis (cut-off
point 50 on the scales, named 'poor performance group') on
the EORTC QLQ-C30 reported a higher klvel ofpsychological
distrs than patients with high levels of function or few
symptoms (Table IV). Between 50% to 80% of patients in
the 'poor performance group' were classified as 'cases' ac-
cording to the GHQ score (>3). A similar strong association
was found for patients reporting a high level of treatment-
related side-effects (head and neck cancer module). Results
are reported for the 'swallowing problem' scale and the four
items with the highest mean scores (Table IV). Similar
clinical and statistical signiiant associations (P<0.01) with
GHQ Likert score were also found for patients with high
level of other symptoms (score > 50) in the head and neck
cancer module, i.e. pain in the mouth, hoarseness, probklms
with talking on the telephone, diziness and headache.
Stepwise multiple regression analyses were performed to
explore the importance of the various QOL scales/single
items and the clinical/demographic variables as predictors of
psychological distress. The GHQ-20 Likert score was treated
as the dependent variable, while the function/symptom scales
in the EORTC QLQ-C30, the 'swallowing problem' scale and
the symptoms items with highest mean score (coughing, trou-
ble with taste, dryness in the mouth and mucus production)
were treated as dichotomised independent variables (see
Materials and methods section). In addition, 11 demo-
graphic/clnical variables were included as independent
variables.
The cognitive and social function scales entered the model
first, followed by pain (explaining 38% of the variance).
Thereafter, stage II entered the model. These four variables
accounted for 40% of the vanance in psychological distress
(Table V). Nimety-six patients (47%) had at kast one ofthese
four attributes. No other variabes had a P-value between
0.001 and 0.05. The constant of 17.6 in Table V represents
the calculated mean GHQ-20 Likert score in patients without
any of the four attributes described in the table. The regres-
sion coeffients represent the increased/decreased score for
each of the attributes in the model. Cognitive function, social
function and stage H also entered the model in the logistic
Table m E pe of scorng with the EORTC QLQ-C30' and the head and neck cancer
module
Way of scoring
Not at A Quite a Very Possible
During the past week aQl littk bit much range
EORTC QLQ-C30 function scales
Has your physxcal condition
or medical trtment interfered with
your social activities?
0-100 transformation 100 66 33 0 0_lOOb
EORTC QLQ-C30 symptom scales
and the head and neck cancer modul
Were you tired?
Has your mouth been dry?
0-100 transformation 0 33 66 100 0OlOff
'The European Organization for Research and Treatment of Cancer Core Quality of Life
Questionnaire, 30-item version. bfHgh score, high level offuncuiming 'High score, high kevel
of symptoms.Psychklocal desh anWd he1 and n ance
K Bjordal and S Kaasa
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Table IV Bivanrate associations between psychological distress measured by GHQ-20 and patient-reported functions
and symptoms in the EORTC QLQ-C30 and the head and neck cancer module
Dependent variable Number (%
Independent GHQ-20 Likert score of 'cases'
variable n mean (s.d.) P* GHQ score P**
EORTC QLQ-C30, functioning scalesa
Physical function High 172 19.6 (9.0) 0.025 47 (27) 0.011
Low 32 23.6 (9.7) 16 (50)
Role function High 141 18.1 (7.6) <0.001 30 (21) <0.001
Low 63 24.9 (10.7) 33 (52)
Social function High 158 17.8 (6.9) <0.001 30 (19) <0.001
Low 46 28.6 (11.1) 33 (72)
Cognitive function High 175 18.3 (7.1) <0.001 40 (23) <0.001
Low 29 31.7 (11.9) 23 (80)
EORTC QLQ-C30. symptom scalesb
Pain Low level of symptoms 175 18.7 (7.8) <0.001 44 (25) <0.001
High level of symptoms 29 29.3 (11.7) 19 (66)
Fatigue Low level of symptoms 164 18.3 (7.7) <0.001 35 (21) <0.001
High level of symptoms 40 27.9 (10.9) 28 (70)
Emesis Low level of symptoms 199 19.8 (8.45) <0.001 59 (30) 0.016
High level of symptoms 5 39.0 (17.6) 4 (80)
Head and neck cancer module
Swallowing problem Low level of symptoms 172 19.0 (8.1) 0.001 43 (25) <0.001
scale High level of symptoms 28 27.3 (11.7) 18 (64)
Coughing Low level of symptoms 172 19.3 (8.6) <0.001 44 (26) <0.001
High level of symptoms 30 25.5 (10.1) 18 (60)
Trouble with taste Low level of symptoms 173 19.6 (8.8) 0.025 47 (27) 0.004
High level of symptoms 30 23.7 (10.9) 16 (53)
Dryness in the mouth Low level of symptoms 146 19.2 (9.1) 0.009 36 (25) 0.002
High level of symptoms 58 22.9 (9.0) 27 (47)
Mucus production Low level of symptoms 144 19.3 (9.2) 0.019 35 (24) <0.001
High level of symptoms 58 22.7 (8.9) 28 (48)
*P-value (ANOVA). **P-value (chi-square). 'High function = mean scale score> 50. Low function = mean scale score
s 50. bLow level of symptoms = mean scale score <50. High level of symptoms = mean scale score > 50. 'Low level of
symptoms = mean scale or single item score <50. High level of symptoms = mean scale or single item score > 50. n
varies because of missing items.
regression analysis. In addition a high level of coughing also
entered the model.
Discasson
The level of psychological distress according to the GHQ-20
(31% of 'cases', 25% satisfying DSM-III criteria, Table II)
was higher than anticipated, on the basis of clinical
experience, in the present cross-sectional study of head and
neck cancer patients. Considering that these patients are
long-term survivors, 7-11 years after treatment, these find-
ings are worrying. The patients have completed the clinical
follow-up programme (which seldom focus on these prob-
lems), and they are not being offered systematic support or
psychological treatment.
A somewhat higher prevalence of depression (40% case
scores in the Geriatric Mental State Schedule) than in this
study was found in a small pilot study of 48 male patients
with buccopharyngeal cancer (age> 60 years) (Morton et al.,
1984). However, these findings can be explained by the
shorter follow-up time (no evidence of disease for at least 6
months), and by the fact that six of the patients had their
larynx removed and 17 of them had receive salvage surgery
after failed radiotherapy. Forty-seven per cent of the patients
receiving salvage surgery were classified as depressed.
To our knowledge, there are no current data on GHQ-20
in a normal population. A lower proportion of 'case scores'
compared with our population was found in male patients in
the age group 55-74 in a population survey in Great Britain
(25% of 'cases', GHQ-30) (Cox et al., 1987). A similar level
of 'cases' in GHQ has been found in patients in general
practice (33%, GHQ-30) (Cleary et al., 1982). However,
Table V Stepwise multiple regression analysis with GHQ-20 Likert
score as the dependent variable
Regression Standard
Independent variablea coefficient error P-value
Low cognitive functionb 8.6 1.6 <0.001
Low social functionb 5.5 1.4 <0.001
High level of painb 5.7 1.6 <0.001
Stage IIC -3.5 1.2 0.006
Constant 17.6 0.6
R2 = 0.40
&Independent variables in the analysis: 12 QOL variables and 11
clinical/demographic variables. bCut-off point = 50. cIn the variance
analysis (ANOVA), patients in stages I, II, III and IV had mean
Likert scores of 20.9, 17.1, 20.6 and 21.6 respectively (P=0.117).
patients with psychological distress have an increased
tendency to seek medical attention (Finlay-Jones and Burvill,
1978). Groups of cancer patients similar to those in our study
are difficult to find owing to the very special composition
with regard to background variables in the latter population.
In a study using the Brief Symptom Inventory, 22% of 273
Hodgkin's disease survivors had a score above the cut-off
point for psychiatric diagnosis (Kornblith et al., 1992). In
another study of the long-term effects of cancer treatment,
young adult cancer patients (50% with Hodgkin's disease)
had similar scores to their neighbours in most areas of
subjective well-being, including a low level of anxiety and
depression measured by the Hospital Anxiety and Depression
(HAD) Scale (frequency of cases not specified) (Olweny et
al., 1993). A high level of psychological distress was found in
a Norwegian study of cancer patients who had receivedK Bjor ad S Kaasa
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palliative radiotherapy; 69% had a 'case' score on GHQ-20,
and the mean Likert score was 27.3 (Kaasa et al., 1993).
The vanety of methods of assessment that have been used
in studies of psychological distrss, anxiety and depression in
cancer patients makes it difficult to compare the findings.
Furthermore, the study populations have been seectd in
various ways from patient populations according to different
criteria. Thus, there seems to be an urgent need for a stan-
dardised method of measurig psychological distress
(anxiety/depression) in cancer patients. In Norway, we are
trying to limit the use of such questionnaires to the GHQ-20
and the HAD scale in clinical cancer trials. The latter scale is
also being used as a standard instrument for measurng
psychological distress by the Medical Research Campaign
(MRC) in the UK.
Psychological support for cancer patients has in general
low priority, probably because of the focus on tumour con-
trol and other physical aspects of the disease in clical trials
and examinations after treatment. Even kss attention has
been paid to psychological factors in cured patients.
And yet it is important to identify patients with such
problems. The most obvious way of doing this is by inter-
views at clinical follow-ups. However, patients suffering from
mood disorders seldom complain spontaneously about their
difficulties, unless the physician poses the appropriate ques-
tions and individual clnicians differ in their ability to detect
psychological disorders (Goldberg, 1984). Moreover, the
patients may not expect the physician to enquire into
psychological areas in check-ups. Both patients and staff
could be under the impresson that depression and anxiety
are inevitable consequences of having cancer. For these
reasons psychological distrs and other symptoms in these
patients are probably under-reported or not diagnosed
(Maguire et al., 1980).
This under-reporting problem could be dealt with in
several ways. One is to include these aspects in the training
of medical students, in connection with the curative
biological end point. Specific training in communication with
patients with life-threatening or chronic diseases is neded
(Razavi et al., 1990), and should be mandatory for all
physicians dealing with cancer patients.
The use of structured interviews and validated question-
naires facilitates the detection of patients with psychological
distrs. The structured psychiatric interview is the best
means we have for diagosing psychological morbidity, but
stuctured interviews are ime-consuming and often require
spial training. A validated questionnaire such as the GHQ-
20 can be used to alert clinicians to the possibility of
psychological disorder in their patients. When this is used in
a clinical setting, and a patient is found to have a 'case'
score, the clinician could follow up on the particular symp-
toms indicated by the patient. A two-step screeing process
like this is hikely to identify most of the patients with a
true-positive 'case' score.
Increased knowledge of the predictors of psychological
distress may help clnicians to identify patients at risk. In the
present study, psychological distress was not significantly
associated with the randomised treatment, which is what we
expected to find. In the univanate analyses, we found a
strong association between psychological distr and the
various QOL variabls, incling most of the items in the
head and neck cancer module. However, redueed cognitive
and social function and pain were the only signiiant QOL
variables in the regression model. It is important to note that
these three variables together explained 38% of the variance
in psychological distres. The reason for the negative assoca-
tion with stage H alone is difficult to explain. Neither the
sociodemographic varbles such as age, gender and educa-
tion nor the other variables reflecting diseaw and treatment
were significantly associated with psychological distress as
measured by GHQ-20 in this population. Thus, the
identification of pain and/or reduced cognitive and social
function in cured patients should alert the physician to the
possible necessity for treatment, including programme
intervention.
Being imited by its cross-sectional design, the present
study could not be used to identify various QOL scales/single
items as prognostic factors for psychological distre. We do
not know whether patients with high levels of psychological
distress report symptoms more readily or whether high levels
of symptoms cause psychoklcal distress. However, in the
study of the validity of the present QOL questionnaire in
head and neck cancer patients, the level of the different
self-reported symptoms r ted the expected acute, subacute
and late toxicity of treatment (Bjordal and Kaasa, 1992). A
prospective longitudinal study of quality of life in head and
neck cancer patiets, with special focus on psychological
distress, has been initiated in Norway and Sweden. It may
provide valid data concerning fluctuations in psychological
distress over time and prognostic factors for psychological
distre during and after treatment.
What can we offer patents identified as suffering from
psychological diste or patients at risk? In a study of
patients undergoing cancer treatment, the large majority of
those (45%) with a psychiatric diagnosis had highly treatable
disorders (Derogatis et al., 1983). However, most patients
identified as having psychological distress will not require
specialist referral, but can be treated in a cost-effective way
by providing social support or medication. All patients are
likely to benefit from optimal communication and support by
the ciniian and the follow-up team, or at the primary health
care lewl.
In the present study, a high prevalence of psychological
distress was found in long-term survivors of head and neck
cancer, especially in patients with impaired cognitive or social
function or with pain. Clinidans need to be aware of this
morbidity, and their ability to detect patients with
psychological disorders needs to be improved. One way of
doing this would be to include specific training in com-
munication in the medical studies. We also need more in-
formation about prognostic factors for psychological dists,
in order to be able to prevent these problems. The GHQ-20
can faciltate this process in a clinical wttng. Ifthese patients
are identified, psychological distress can be reduced and
treated, and the patients might be able to cope more
effectively, which may improve their quality of life.
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